Concepedia

Alexander Renziehausen

AR

Statistics

Publications

9

Citations

388

H-Index

9

Active since

2018

Affiliations

Imperial College London(Current)

University of Ioannina

Hammersmith Hospital

Royal Surrey County Hospital

Charing Cross Hospital

Alexander Renziehausen is an author at Imperial College London specializing in oncology, pharmacology, and glioblastoma drug therapy.

ORCID

Publications per year

2018–2022

9

Publications

9

Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer's disease

Loukia Katsouri, Amy M. Birch, Alexander Renziehausen et al. · Glia · 2019 · 80 citations · Full text

, , +17

Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM

Justyna M. Przystal, Nabil Hajji, Combiz Khozoie et al. · Cell Death and Disease · 2018 · 59 citations · Full text

, , +17

The S100A4 Protein Signals through the ErbB4 Receptor to Promote Neuronal Survival

Stanislava Pankratova, Jörg Klingelhöfer, Oksana Dmytriyeva et al. · Theranostics · 2018 · 54 citations · Full text

, , +17

The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention

Alexander Renziehausen, He‐Xiao Wang, Bhavya Rao et al. · Oncogene · 2018 · 51 citations · Full text

, , +17

Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma

Alexander Renziehausen, Antonis D. Tsiailanis, Richard Perryman et al. · Molecular Cancer Therapeutics · 2019 · 42 citations · Full text

, , +17

1–5 of 9